Login / Signup

Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study.

Roy M FleischmannPeter WinkleJesse HallShakti ValdezSha LiuXiaohong YanLiz HicksCaroline LeeJeffrey N MinerMichael GillenMartha Hernandez-Illas
Published in: RMD open (2018)
NCT02246673.
Keyphrases
  • open label
  • squamous cell carcinoma
  • phase ii
  • metabolic syndrome
  • phase iii